Eli Lilly and Company

Pharmareferent (m/w/d) Diabetes und Kardiometabolic Gebiet 310405 (Bad Oeynhausen, Bünde, Minden, Lemgo)

Germany

Not SpecifiedCompensation
Entry Level & New GradExperience Level
Full TimeJob Type
UnknownVisa
Healthcare, PharmaceuticalsIndustries

Position Overview

  • Location Type: Onsite
  • Employment Type: Full-time
  • Duration: 18 Months (Fixed Term)
  • Location: Bad Homburg vor der Höhe (Hessen), Germany

Eli Lilly and Company (referred to as Lilly) is a global healthcare leader headquartered in Indianapolis, Indiana. With over 45,000 employees worldwide, Lilly is dedicated to discovering and bringing life-changing medicines to those who need them, improving the understanding and management of disease, and giving back to communities through philanthropy and volunteerism. Lilly’s core therapeutic and research areas include Alzheimer's disease, pain, cancer, immunology, diabetes, and obesity. Lilly Deutschland GmbH, a subsidiary of Eli Lilly and Company, is located in Bad Homburg vor der Höhe (Hessen) and was founded in 1960, employing over 1,100 people. Lilly’s mission is to positively change the lives of people – through the exploration of medicines, a better understanding of disease management, and by supporting patients, their families, and friends. Lilly has a rich history of scientific breakthroughs and has developed life-changing medications and therapeutic options for some of the world's most challenging health problems.

Job Title

Pharmareferent (m/w/d) Diabetes and Cardiometabolic Area

Location

Bad Oeynhausen, Bünde, Minden, Lemgo

Responsibilities

  • (Specific responsibilities are not detailed in the provided text. Further information would be needed to complete this section.)

Requirements

  • (Specific requirements are not detailed in the provided text. Further information would be needed to complete this section.)

Benefits

  • Positive Work Atmosphere: An egalitarian environment with a strong team spirit.
  • Creative Freedom: Opportunity to contribute ideas and implement them independently, as part of cross-functional or self-organized teams.
  • Work-Life Balance: Flexible working hours based on trust.
  • Professional Development: Individual career development support and access to professional training through the "Corporate Lilly University" globally.

Company Information

  • Company Name: Eli Lilly and Company
  • Founded: 1876 (Indianapolis, Indiana)
  • Global Employees: Over 51 million people rely on Lilly’s medications worldwide.
  • Main Therapeutic Areas: Alzheimer’s disease, pain, cancer, immunology, diabetes, and obesity.
  • German Subsidiary: Lilly Deutschland GmbH, headquartered in Bad Homburg vor der Höhe (Hessen).

Skills

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI